PMC:7600245 / 21095-21266 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T95","span":{"begin":56,"end":66},"obj":"Body_part"},{"id":"T96","span":{"begin":116,"end":121},"obj":"Body_part"}],"attributes":[{"id":"A95","pred":"fma_id","subj":"T95","obj":"http://purl.org/sig/ont/fma/fma7199"},{"id":"A96","pred":"fma_id","subj":"T96","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":", is that it increases the drug’s oral bioavailability, intestinal diffusion, selectivity of targeting the infected cells, and intracellular half-life. It also decreases t"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T195","span":{"begin":56,"end":66},"obj":"http://purl.obolibrary.org/obo/UBERON_0000160"},{"id":"T196","span":{"begin":56,"end":66},"obj":"http://www.ebi.ac.uk/efo/EFO_0000834"},{"id":"T197","span":{"begin":116,"end":121},"obj":"http://purl.obolibrary.org/obo/GO_0005623"}],"text":", is that it increases the drug’s oral bioavailability, intestinal diffusion, selectivity of targeting the infected cells, and intracellular half-life. It also decreases t"}

{"project":"LitCovid-PubTator","denotations":[{"id":"581","span":{"begin":107,"end":115},"obj":"Disease"}],"attributes":[{"id":"A581","pred":"tao:has_database_id","subj":"581","obj":"MESH:D007239"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":", is that it increases the drug’s oral bioavailability, intestinal diffusion, selectivity of targeting the infected cells, and intracellular half-life. It also decreases t"}